License, Distribution and Supply Agreement to market Neridronic Acid in China, Hong Kong, Macau and TaiwanLicense, Distribution and Supply Agreement • April 11th, 2014
Contract Type FiledApril 11th, 2014Hong Kong, 11 April 2014 - Lee’s Pharmaceutical Holdings Limited (“the Group” or “Lee’s”) (Main Board Stock Code: 0950; Website: www.leespharm.com) and Abiogen Pharma S.p.A. of Pisa, Italy today jointly announced the signing of an agreement for License, Distribution and Supply for marketing of Attila® (Neridronic Acid) throughout China, Hong Kong, Macau and Taiwan.